Phibro Anl Htlh A (PAHC) Stock Price, Quote & News

Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, su...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 201 329 7300

Website: www.pahc.com

Address:

Glenpointe Centre East, 3rd Floor Suite 21 300 Frank West Burr Boulevard, Teaneck, United States

Bigeyes2 Feb. 6 at 1:05 AM

$PAHC cup and handle but 5th wave

0 · Reply

Godwins26 Feb. 5 at 9:03 PM

Watchlist for the week $XTKG It's time 😊 $SITM $KELYB $PAHC $KLIC

0 · Reply

MichaelDV Feb. 5 at 8:30 PM

$PAHC Low attention, but accumulation could be setting up a shift if liquidity increases

0 · Reply

MichaelDV Feb. 5 at 5:03 PM

$PAHC Watching for trend confirmation, volume expansion could fuel upside

0 · Reply

topstockalerts Feb. 5 at 4:46 PM

$PAHC Big move developing as buyers pile in 😮. Price is moving with force. This is real momentum.

0 · Reply

MichaelDV Feb. 5 at 4:35 PM

$PAHC Watching for trend confirmation, needs volume support to fuel the next move

0 · Reply

bowlerhatsftw Feb. 5 at 3:58 PM

$PAHC EPS YOY on this thing🤔

0 · Reply

OldManGrumble Feb. 4 at 10:54 PM

$PAHC

0 · Reply

StocktwitsEarnings Feb. 4 at 9:25 PM

$PAHC Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.68 up 750.00% YoY • Reported revenue of $373.91M up 20.90% YoY

0 · Reply

EntropyX Feb. 4 at 1:46 PM

$PAHC is an animal health company focused on vaccines and pharmaceuticals; demand is stable, but growth is modest and competition from large players is significant.

0 · Reply

Phibro Animal Health Corporation (PAHC) Q2 2026 Earnings Call Transcript

Feb 4, 2026, 4:25 PM EST - 1 day ago

Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance

Feb 3, 2026, 4:10 PM EST - 2 days ago

Phibro Animal Health Corporation Declares Quarterly Dividend

Jan 28, 2026, 4:30 PM EST - 8 days ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Second Quarter Results

Dec 18, 2025, 4:10 PM EST - 7 weeks ago

Phibro Animal Health Corporation Announces Leadership Transition

Nov 6, 2025, 2:36 PM EST - 3 months ago

Phibro Animal Health Corporation (PAHC) Q1 2026 Earnings Call Transcript

Nov 5, 2025, 4:22 PM EST - 3 months ago

Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance

Oct 30, 2025, 1:00 PM EDT - 3 months ago

Phibro Animal Health Corporation Announces National Launch of Restoris™ Piezoelectric Dental Gel for Dogs

Oct 29, 2025, 4:00 PM EDT - 3 months ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results

Oct 9, 2025, 4:30 PM EDT - 4 months ago

Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Periodontal Health Asset for Dogs

Sep 9, 2025, 5:21 PM EDT - 5 months ago

Phibro Animal Health Corporation (PAHC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 2, 2025, 4:00 PM EDT - 5 months ago

Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference

Sep 2, 2025, 9:15 AM EDT - 5 months ago

Phibro Animal Health: Zoetis Growth, Valuation Still Attractive

Aug 28, 2025, 12:29 PM EDT - 5 months ago

Phibro Animal Health Corporation (PAHC) Q4 2025 Earnings Conference Call Transcript

Aug 27, 2025, 4:57 PM EDT - 5 months ago

Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance

Aug 20, 2025, 4:00 PM EDT - 6 months ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2025 Results

Jul 7, 2025, 5:00 PM EDT - 7 months ago

Overlooked Stock: PAHC Taps 4-Year High

Jul 7, 2025, 2:30 PM EDT - 7 months ago

Phibro's Feed Play Pays Off: JPMorgan Upgrades On Zoetis Deal Boost

Jun 25, 2025, 4:19 AM EDT - 8 months ago

Phibro Animal Health: The Animal Is Unleashed

May 22, 2025, 4:00 PM EDT - 9 months ago

Phibro Animal Health Corporation to Participate at Stifel Jaws & Paws Conference

May 10, 2025, 3:40 PM EDT - 9 months ago

Phibro Animal Health Corporation (PAHC) Q3 2025 Earnings Call Transcript

May 7, 2025, 4:30 PM EDT - 9 months ago

Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance

Apr 23, 2025, 4:00 PM EDT - 10 months ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results

Mar 5, 2025, 4:00 PM EST - 1 year ago

Phibro Animal Health Corporation to Participate at Barclays Annual Global Healthcare Conference

Feb 20, 2025, 4:00 PM EST - 1 year ago

Phibro Animal Health Corporation to Participate at Bank of America 2025 Virtual Animal Health Summit

Feb 13, 2025, 8:15 AM EST - 1 year ago

Phibro Animal Health Is Cruising With Its Recent Zoetis Acquisition

ZTS

Feb 6, 2025, 1:26 PM EST - 1 year ago

Phibro Animal Health Corporation (PAHC) Q2 2025 Earnings Call Transcript

Jan 23, 2025, 4:45 PM EST - 1 year ago

Phibro Animal Health Corporation Announces the Appointment of Joyce J. Lee to Its Board of Directors

Nov 8, 2024, 8:31 PM EST - 1 year ago

Phibro Animal Health Corporation (PAHC) Q1 2025 Earnings Call Transcript

Oct 31, 2024, 4:10 PM EDT - 1 year ago

Phibro Animal Health Corporation Completes Acquisition of Zoetis' Medicated Feed Additive Product Portfolio and Certain Water-Soluble Products

ZTS

Aug 29, 2024, 6:08 PM EDT - 1 year ago

Phibro Animal Health Corporation (PAHC) Q4 2024 Earnings Call Transcript

Aug 14, 2024, 4:00 PM EDT - 1 year ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2024 Results

Jun 5, 2024, 4:00 PM EDT - 1 year ago

Phibro Animal Health Corporation Releases Third Annual ESG Report: Connections that Advance Animal Health, Nutrition and Sustainability

May 20, 2024, 4:00 PM EDT - 1 year ago

Phibro Animal Health Corporation to Participate in Stifel Dental and Animal Health (Jaws & Paws) Conference

May 10, 2024, 1:43 PM EDT - 1 year ago

Phibro Animal Health Corporation (PAHC) Q3 2024 Earnings Call Transcript

Apr 28, 2024, 6:30 PM EDT - 1 year ago

Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health

ZTS

Feb 29, 2024, 4:00 PM EST - 2 years ago

Phibro Animal Health Corporation to Participate in Barclays Global Healthcare Conference

Feb 14, 2024, 4:00 PM EST - 2 years ago

Phibro Animal Health Corporation to Participate in Bank of America 2024 Animal Health Summit

Feb 8, 2024, 3:55 PM EST - 2 years ago

Phibro Animal Health Corporation (PAHC) Q2 2024 Earnings Call Transcript

Feb 6, 2024, 8:30 AM EST - 2 years ago

Phibro Animal Health Corporation Announces Chief Financial Officer Changes

Nov 20, 2023, 8:53 PM EST - 2 years ago

Phibro Animal Health: Vaccine App And Analysts' Expectations Imply Undervaluation

Nov 10, 2023, 11:35 AM EST - 2 years ago

Phibro Animal Health Corporation (PAHC) Q1 2024 Earnings Call Transcript

Nov 7, 2023, 10:23 AM EST - 2 years ago

Phibro Animal Health Corporation Reiterates Safety of Mecadox® and Intent to Defend its Use for Customers

Aug 31, 2023, 1:27 PM EDT - 2 years ago

Phibro Animal Health Corporation (PAHC) Q4 2023 Earnings Call Transcript

Jul 31, 2023, 4:00 PM EDT - 2 years ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2023 Results

May 8, 2023, 4:01 PM EDT - 2 years ago

Phibro Issues Second Environmental, Social and Governance Report

May 6, 2023, 5:28 PM EDT - 2 years ago

Phibro Animal Health Corporation (PAHC) Q3 2023 Earnings Call Transcript

May 3, 2023, 4:30 PM EDT - 3 years ago

Phibro Animal Health Corporation Reports Third Quarter and Year-to-Date Results

Apr 13, 2023, 4:00 PM EDT - 3 years ago

Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Financial Results

Apr 5, 2023, 4:00 PM EDT - 3 years ago

Phibro Animal Health Corporation to Participate in Bank of America Securities 2023 Health Care Conference.

Bigeyes2 Feb. 6 at 1:05 AM

$PAHC cup and handle but 5th wave

0 · Reply

Godwins26 Feb. 5 at 9:03 PM

Watchlist for the week $XTKG It's time 😊 $SITM $KELYB $PAHC $KLIC

0 · Reply

MichaelDV Feb. 5 at 8:30 PM

$PAHC Low attention, but accumulation could be setting up a shift if liquidity increases

0 · Reply

MichaelDV Feb. 5 at 5:03 PM

$PAHC Watching for trend confirmation, volume expansion could fuel upside

0 · Reply

topstockalerts Feb. 5 at 4:46 PM

$PAHC Big move developing as buyers pile in 😮. Price is moving with force. This is real momentum.

0 · Reply

MichaelDV Feb. 5 at 4:35 PM

$PAHC Watching for trend confirmation, needs volume support to fuel the next move

0 · Reply

bowlerhatsftw Feb. 5 at 3:58 PM

$PAHC EPS YOY on this thing🤔

0 · Reply

OldManGrumble Feb. 4 at 10:54 PM

$PAHC

0 · Reply

StocktwitsEarnings Feb. 4 at 9:25 PM

$PAHC Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.68 up 750.00% YoY • Reported revenue of $373.91M up 20.90% YoY

0 · Reply

EntropyX Feb. 4 at 1:46 PM

$PAHC is an animal health company focused on vaccines and pharmaceuticals; demand is stable, but growth is modest and competition from large players is significant.

0 · Reply

OldManGrumble Feb. 2 at 4:20 AM

$PAHC Good business

0 · Reply

ZacksResearch Jan. 28 at 12:54 PM

$PAHC set for Q2 growth — are expectations too high? 🚀 📈 Zacks Consensus Estimate points to 27.8% EPS growth YoY 🐾 Animal Health segment bolstered by Zoetis integration & new product launches 📉 But Mineral Nutrition sales could dip 8.7% YoY Opportunity assessment here 👉 https://www.zacks.com/stock/news/2824040/pahc-q2-earnings-preview-animal-health-momentum-likely-to-aid-results?cid=sm-stocktwits-2-2824040-body-30591&ADID=SYND_STOCKTWITS_TWEET_2_2824040_BODY_30591

0 · Reply

ZacksResearch Jan. 28 at 11:54 AM

Animal Health momentum heading into earnings for $PAHC? 🐾📈 This Q2 setup is getting interesting. The Q2 earnings preview points to Animal Health momentum likely aiding results, putting that segment front and center as a potential driver this quarter. See what this could mean for the stock 👉 https://www.zacks.com/stock/news/2824040/pahc-q2-earnings-preview-animal-health-momentum-likely-to-aid-results?cid=sm-stocktwits-2-2824040-teaser-30588&ADID=SYND_STOCKTWITS_TWEET_2_2824040_TEASER_30588

0 · Reply

BillionerOfKing Jan. 23 at 4:47 PM

$PAHC Current Stock Price: $38.71 Contracts to trade: $40 PAHC Feb 20 2026 Call Entry: $0.50 Exit: $0.85 ROI: 69% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

ZacksResearch Jan. 15 at 4:18 PM

$PAHC has surged 90.9% in the past year! 🚀 What's fueling this impressive rally? 📈 Vaccine business net sales up 25% in the first quarter of fiscal 2026, driven by growth in poultry products in Latin America and higher international demand. 🌍 Expanding vaccine operations in high-growth regions like Latin America and Asia. Discover the full story behind PAHC's momentum here 👉 https://www.zacks.com/stock/news/2818095/phibro-animal-health-stock-climbs-909-in-a-year-whats-driving-it?cid=sm-stocktwits-2-2818095-body-29087&ADID=SYND_STOCKTWITS_TWEET_2_2818095_BODY_29087

0 · Reply

ZacksResearch Jan. 15 at 3:18 PM

$PAHC up 90.9% in a year — and this rally isn’t random. 🚀 Shares are surging on booming vaccine sales, new capacity coming online in Brazil, and rapid growth across emerging markets — a powerful combo driving momentum. Find out what’s really fueling PAHC’s breakout 👉 https://www.zacks.com/stock/news/2818095/phibro-animal-health-stock-climbs-909-in-a-year-whats-driving-it?cid=sm-stocktwits-2-2818095-teaser-29082&ADID=SYND_STOCKTWITS_TWEET_2_2818095_TEASER_29082

0 · Reply

TheRealShortSqueezy Jan. 14 at 2:30 PM

$PETV Just Dropped News 📰 Digital Landia’s AgenticPet surpassed 1,000+ active beta users in under 72 hours, signaling strong demand for AI-powered preventive pet healthcare. Key highlights: 🔸1,000+ beta users onboarded under 72 hours 🔸 Confirms demand for proactive, AI-driven pet health monitoring 🔸 Powered by 10 specialized AI agents (Veterinarian, Behaviorist, Geneticist, Radiologist, etc.) 🔸 Early users report detection of health, stress, and behavioral issues previously unnoticed 🔸 Backed by an exclusive 10-year partnership with PetVivo Holdings 🔸 Partnership provides access to ~8,500 veterinary clinics nationwide Momentum is building and PETV sits at the center of AI-driven preventive pet care. Communicated Disclaimer: https://stockresearchtoday.com/better-pet-care-through-joint-therapy-solutions/ Sector Peers: $ZTS $IDXX $ELAN $PAHC

0 · Reply

TheRealShortSqueezy Jan. 6 at 2:35 PM

$PETV : From Vet Devices to AI Powerhouse 🐾 PetVivo Holdings develops FDA approved regenerative veterinary devices and is now leveraging its installed base to launch a high-margin AI diagnostic platform. The foundation➡️ The Device Business: ➖ SPRYNG & PrecisePRP FDA-approved regenerative veterinary devices ➖1,000+ veterinary clinics actively using PetVivo products ➖7,300+ veterinarians in the distribution network ➖30% gross margins with stable, repeat revenue The Catalyst ➡️The AI Platform: ➖ http://PetVivo.ai launching Q1 2026 (≈ 90 days away) ➖ 10 specialized AI diagnostic agents ➖ 80–90% gross margins, a massive step-change from devices The market opportunity: Wall Street is valuing PetVivo as a low multiple veterinary device company (~$45M market cap), while the company is evolving into an AI-driven platform that could justify a $360M – $1.35B+ valuation. Communicated Disclaimer: https://stockresearchtoday.com/better-pet-care-through-joint-therapy-solutions/ Sector Peers: $ZTS $IDXX $ELAN $PAHC

1 · Reply

ProverbsP Dec. 27 at 5:41 AM

$PAHC Markets appear to be rewarding companies that show durable execution rather than rapid narrative shifts. Margins must hold as the company navigates cost pressure. Credible progress tends to compress risk premiums. Execution quality becomes the defining catalyst from here.

0 · Reply

ZacksResearch Dec. 16 at 1:34 PM

$PAHC surged 93.7% in the past year — is the rally sustainable? 🚀 🐔 Strong growth in Animal Health, with MFA revenues up 81% in Q1 FY26 in nutritional specialties and vaccines 🌍 Expanding vaccine business and global footprint in approximately 90 countries 📈 Zacks Rank #1 and a 23.7% earnings surprise last quarter Discover why PAHC could keep climbing 👉 https://www.zacks.com/stock/news/2804780/is-phibro-animal-health-stock-a-smart-addition-to-your-portfolio-now?cid=sm-stocktwits-2-2804780-body-24958&ADID=SYND_STOCKTWITS_TWEET_2_2804780_BODY_24958

0 · Reply

ZacksResearch Dec. 16 at 12:07 PM

$PAHC riding a powerful Animal Health wave — but risks aren’t gone 🚀 Animal Health momentum, vaccine growth, and rising emerging market demand are driving the story, even as macro pressure and competitive risks continue to linger in the background. See the full bull vs. risk breakdown here 👉 https://www.zacks.com/stock/news/2804780/is-phibro-animal-health-stock-a-smart-addition-to-your-portfolio-now?cid=sm-stocktwits-2-2804780-teaser-24922&ADID=SYND_STOCKTWITS_TWEET_2_2804780_TEASER_24922

0 · Reply

ZacksResearch Dec. 10 at 2:41 PM

$PAHC up 59.6% so far this year — what's driving the surge? 🚀 🐾 Animal Health biz momentum & vaccine growth 🌍 Expanding in high-growth regions like Brazil & Southeast Asia 📈 Fiscal 2026 EPS expected to jump 32.1% Discover the full growth story here 👉 https://www.zacks.com/stock/news/2802112/phibro-animal-health-stock-climbs-596-ytd-whats-driving-it?cid=sm-stocktwits-2-2802112-body-24201&ADID=SYND_STOCKTWITS_TWEET_2_2802112_BODY_24201

0 · Reply

Market Cap	1.66B
Revenue (ttm)	1.30B
Net Income (ttm)	48.26M
EPS (ttm)	N/A
PE Ratio	16.72
Forward PE	14.98
Profit Margin	3.72%
Debt to Equity Ratio	2.38

Volume	981,900
Avg Vol	257,978
Day's Range	N/A - N/A
Shares Out	40.53M
Stochastic %K	100%
Beta	0.80
Analysts	Sell
Price Target	$41.00